Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216469 · ClinicalTrials.gov registry record

A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography

A clinical trial of Amyloidosis, sponsored by Mayo Clinic.

Recruiting
Registry status
20
Enrollment target
1
Study location

NCT07216469 is a study of Amyloidosis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 1,128-participant average among 28 other Amyloidosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216469, a study of Amyloidosis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.

Conditions Studied

Amyloidosis

Interventions

  • DIAGNOSTIC_TEST Magnetic Resonance Elastography (MRE)

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-10-14
Est. Completion 2027-11

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07216469

The ClinicalTrials.gov registry entry for NCT07216469 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,128-participant average among 28 other Amyloidosis trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyloidosis appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Elastography (MRE) is the first listed.

NCT07216469 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07216469 about?

NCT07216469 is a clinical study titled "A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography". This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance elastography (MRE) in patients with cardiac amyloidosis.

What is the current status of trial NCT07216469?

This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-10-14. Estimated completion is 2027-11.

What conditions does trial NCT07216469 study?

This clinical trial studies the following conditions: Amyloidosis.

What interventions are being tested in trial NCT07216469?

The interventions under investigation include: Magnetic Resonance Elastography (MRE) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07216469?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07216469 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyloidosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyloidosis

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.